Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes

Life Sciences

Volumn 145, Issue , 2016, Pages 34-41

  Emamgholipour, Solaleh ^a   Hossein Nezhad, Arash ^b,c   Sahraian, Mohammad Ali ^d   Askarisadr, Fatemeh ^e   Ansari, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BOSTON UNIVERSITY   (United States)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Catalase; Melatonin; MnSOD; Multiple sclerosis; Oxidative stress; SIRT1

Indexed keywords

CATALASE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; MESSENGER RNA; SIRTUIN 1; ANTIOXIDANT; SUPEROXIDE DISMUTASE;

ADOLESCENT; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; ADULT; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MONONUCLEAR CELL; YOUNG ADULT;

ADULT; ANTIOXIDANTS; CATALASE; CELL SURVIVAL; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MELATONIN; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; SIRTUIN 1; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84950286987     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.12.014     Document Type: Article

References (55)

1. R.A. Marrie Environmental risk factors in multiple sclerosis aetiology Lancet Neurol. 3 12 Dec 2004 709 718
2. S. Emamgholipour, S.M. Eshaghi, A. Hossein-nezhad, K. Mirzaei, Z. Maghbooli, and M.A. Sahraian Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease PLoS ONE 8 10 2013 e76555
3. C.H. Polman, S.C. Reingold, B. Banwell, M. Clanet, J.A. Cohen, M. Filippi, and et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann. Neurol. 69 2 Feb 2011 292 302
4. G. Schreibelt, J. van Horssen, S. van Rossum, C.D. Dijkstra, B. Drukarch, and H.E. de Vries Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology Brain Res. Rev. 56 2 Dec 2007 322 330
5. J. van Horssen, M.E. Witte, G. Schreibelt, and H.E. de Vries Radical changes in multiple sclerosis pathogenesis Biochim. Biophys. Acta 1812 2 Feb 2011 141 150
6. H. Lassmann Pathology and disease mechanisms in different stages of multiple sclerosis J. Neurol. Sci. 333 1-2 Oct 15 2013 1 4
7. M. Gironi, B. Borgiani, E. Mariani, C. Cursano, L. Mendozzi, R. Cavarretta, and et al. Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment J. Immunol. Res. 2014 2014 961863
8. S.R. Oliveira, A.P. Kallaur, A.N. Simao, H.K. Morimoto, J. Lopes, C. Panis, and et al. Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale J. Neurol. Sci. 321 1-2 Oct 15 2012 49 53
9. J. van Horssen, G. Schreibelt, J. Drexhage, T. Hazes, C.D. Dijkstra, P. van der Valk, and et al. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression Free Radic. Biol. Med. 45 12 Dec 15 2008 1729 1737
10. A. Fiorini, T. Koudriavtseva, E. Bucaj, R. Coccia, C. Foppoli, A. Giorgi, and et al. Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis PLoS ONE 8 6 2013 e65184
11. I. Tasset, E. Aguera, F. Sanchez-Lopez, M. Feijoo, A.I. Giraldo, A.H. Cruz, and et al. Peripheral oxidative stress in relapsing-remitting multiple sclerosis Clin. Biochem. 45 6 Apr 2012 440 444
12. J. Zhang, S.M. Lee, S. Shannon, B. Gao, W. Chen, A. Chen, and et al. The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice J. Clin. Invest. 119 10 Oct 2009 3048 3058
13. C.A. Tegla, P. Azimzadeh, M. Andrian-Albescu, A. Martin, C.D. Cudrici, R. Trippe III, and et al. SIRT1 is decreased during relapses in patients with multiple sclerosis Exp. Mol. Pathol. 96 2 Apr 2014 139 148
14. X.X. Kong, R. Wang, X.J. Liu, L.L. Zhu, D. Shao, Y.S. Chang, and et al. Function of SIRT1 in physiology Biochemistry (Mosc) 74 7 Jul 2009 703 708
15. Z.Z. Chong, Y.C. Shang, S. Wang, and K. Maiese SIRT1: new avenues of discovery for disorders of oxidative stress Expert Opin. Ther. Targets 16 2 Feb 2012 167 178
16. L. Rehan, K. Laszki-Szcząchor, M. Sobieszczańska, and D. Polak-Jonkisz SIRT1 and NAD as regulators of ageing Life Sci. 105 1 2014 1 6
17. Y. Cheng, H. Takeuchi, Y. Sonobe, S. Jin, Y. Wang, H. Horiuchi, and et al. Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes J. Neuroimmunol. 269 1-2 Apr 15 2014 38 43
18. J.M. Yun, A. Chien, I. Jialal, and S. Devaraj Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights J. Nutr. Biochem. 23 7 Jul 2012 699 705
19. G. Donmez, and T.F. Outeiro SIRT1 and SIRT2: emerging targets in neurodegeneration EMBO Mol. Med. 5 3 2013 344 352
20. M. Pallàs, G. Casadesús, M.A. Smith, A. Coto-Montes, C. Pelegri, J. Vilaplana, and et al. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection Curr. Neurovasc. Res. 6 1 2009 70 81
21. Y. Gilgun-Sherki, E. Melamed, and D. Offen The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J. Neurol. 251 3 2004 Mar 261 268
22. E. Miller, B. Wachowicz, and I. Majsterek Advances in antioxidative therapy of multiple sclerosis Curr. Med. Chem. 20 37 2013 4720 4730
23. A. Galano, D.X. Tan, and R.J. Reiter Melatonin as a natural ally against oxidative stress: a physicochemical examination J. Pineal Res. 51 1 Aug 2011 1 16
24. R.J. Reiter, D. Melchiorri, E. Sewerynek, B. Poeggeler, L. Barlow-Walden, J. Chuang, and et al. A review of the evidence supporting melatonin's role as an antioxidant J. Pineal Res. 18 1 Jan 1995 1 11
25. C. Rodriguez, J.C. Mayo, R.M. Sainz, I. Antolin, F. Herrera, V. Martin, and et al. Regulation of antioxidant enzymes: a significant role for melatonin J. Pineal Res. 36 1 Jan 2004 1 9
26. L. Melamud, D. Golan, R. Luboshitzky, I. Lavi, and A. Miller Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis J. Neurol. Sci. 314 1-2 Mar 15 2012 37 40
27. N. Farhadi, S. Oryan, and M. Nabiuni Serum levels of melatonin and cytokines in multiple sclerosis Biomed J. 37 2 Mar-Apr 2014 90 92
28. T. Gholipour, T. Ghazizadeh, S. Babapour, B. Mansouri, M. Ghafarpour, B. Siroos, and et al. Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis Iran. J. Allergy Asthma Immunol. 14 1 Feb 2015 91 97
29. A. Damasceno, A.S. Moraes, A. Farias, B.P. Damasceno, L.M. Dos Santos, and F. Cendes Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: a preliminary study J. Neurol. Sci. 353 1-2 Jun 15 2015 166 168
30. M. Adamczyk-Sowa, K. Pierzchala, P. Sowa, S. Mucha, I. Sadowska-Bartosz, J. Adamczyk, and et al. Melatonin acts as antioxidant and improves sleep in MS patients Neurochem. Res. 39 8 Aug 2014 1585 1593
31. M. Adamczyk-Sowa, K. Pierzchala, P. Sowa, R. Polaniak, M. Kukla, and M. Hartel Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients J. Physiol. Pharmacol. 65 4 Aug 2014 543 550
32. E. Miller, A. Walczak, I. Majsterek, and J. Kedziora Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course J. Neuroimmunol. 257 1-2 Apr 15 2013 97 101
33. J. Hong, Y.C. Zang, G. Hutton, V.M. Rivera, and J.Z. Zhang Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis J. Neuroimmunol. 152 1-2 Jul 2004 126 139
34. H.-Y. Chiu, L.-Y. Tsao, and R.-C. Yang Heat-shock response protects peripheral blood mononuclear cells (PBMCs) from hydrogen peroxide-induced mitochondrial disturbance Cell Stress Chaperones 14 2 2009 207 217
35. I.F. Benzie, and J.J. Strain The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay Anal. Biochem. 239 1 Jul 15 1996 70 76
36. N.J. Kruger The Bradford method for protein quantitation The Protein Protocols Handbook 2009 Springer 17 24
37. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat. Protoc. 3 6 2008 1101 1108
38. R.E. Gonsette Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity J. Neurol. Sci. 274 1-2 Nov 15 2008 48 53
39. A. Lopez-Gonzalez, N. Alvarez-Sanchez, P.J. Lardone, I. Cruz-Chamorro, A. Martinez-Lopez, J.M. Guerrero, and et al. Melatonin treatment improves primary progressive multiple sclerosis: a case report J. Pineal Res. 58 2 Mar 2015 173 177
40. M. Karlik, P. Valkovic, V. Hancinova, L. Krizova, L. Tothova, and P. Celec Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis Clin Biochem. Oct 7 2014
41. S. Ljubisavljevic, I. Stojanovic, S. Vojinovic, D. Stojanov, S. Stojanovic, G. Kocic, and et al. Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic Cell. Mol. Neurobiol. 33 6 Aug 2013 767 777
42. K. Socha, J. Kochanowicz, E. Karpinska, J. Soroczynska, M. Jakoniuk, Z. Mariak, and et al. Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis Nutr. J. 13 2014 62
43. G. Pennisi, C. Cornelius, M.M. Cavallaro, A.T. Salinaro, M.T. Cambria, M. Pennisi, and et al. Redox regulation of cellular stress response in multiple sclerosis Biochem. Pharmacol. 82 10 Nov 15 2011 1490 1499
44. M. Kopff, I. Zakrzewska, J. Czernicki, J. Klem, and M. Strzelczyk Red cell superoxide dismutase and catalase activity in multiple sclerosis Acta Biochim. Pol. 40 1 1993 154 157
45. E. Gray, K. Kemp, K. Hares, J. Redondo, C. Rice, N. Scolding, and et al. Increased microglial catalase activity in multiple sclerosis grey matter Brain Res. 1559 Apr 22 2014 55 64
46. C. Tomás-Zapico, and A. Coto-Montes Melatonin as antioxidant under pathological processes Recent Pat. Endocr. Metab. Immune Drug Discovery 1 1 2007 63 82
47. B.M. Hybertson, B. Gao, S.K. Bose, and J.M. McCord Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation Mol. Asp. Med. 32 4-6 Aug 2011 234 246
48. R. Rodrigo, J.C. Prieto, and R. Castillo Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n - 3 fatty acids: molecular mechanisms and potential clinical applications Clin. Sci. (Lond.) 124 1 Jan 2013 1 15
49. W. He, Y. Wang, M.Z. Zhang, L. You, L.S. Davis, H. Fan, and et al. Sirt1 activation protects the mouse renal medulla from oxidative injury J. Clin. Invest. 120 4 Apr 2010 1056 1068
50. H. Yao, I.K. Sundar, T. Ahmad, C. Lerner, J. Gerloff, A.E. Friedman, and et al. SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism Am. J. Physiol. Lung Cell. Mol. Physiol. 306 9 May 1 2014 L816 L828
51. R.S. Khan, K. Dine, J. Das Sarma, and K.S. Shindler SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease Acta Neuropathol. Commun. 2 2014 3
52. V.K. Nimmagadda, C.T. Bever, N.R. Vattikunta, S. Talat, V. Ahmad, N.K. Nagalla, and et al. Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets J. Immunol. 190 9 May 1 2013 4595 4607
53. A. Mirshafiey, and M. Mohsenzadegan Antioxidant therapy in multiple sclerosis Immunopharmacol. Immunotoxicol. 31 1 2009 13 29
54. J. van Horssen, J.A. Drexhage, T. Flor, W. Gerritsen, P. van der Valk, and H.E. de Vries Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions Free Radic. Biol. Med. 49 8 Nov 1 2010 1283 1289
55. I.R. Kashani, Z. Rajabi, M. Akbari, G. Hassanzadeh, A. Mohseni, M.K. Eramsadati, and et al. Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis Exp. Brain Res. 232 9 Sep 2014 2835 2846